Hugh Harley

Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3

Mitchell L. Shiffman, Fredy Suter, Bruce R. Bacon et al. · New England Journal of Medicine · 2007 · 490 citations · Full text

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B

Peter Angus, Geoffrey W. McCaughan, Edward Gane et al. · Liver Transplantation · 2000 · 250 citations

Analysis of ISG Expression in Chronic Hepatitis C Identifies Viperin as a Potential Antiviral Effector *

Karla J. Helbig, Daryl Lau, Ljiljana Semendric et al. · Hepatology · 2005 · 231 citations · Full text

Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation

Karla J. Helbig, Andrew Ruszkiewicz, Ljiljana Semendric et al. · Hepatology · 2004 · 110 citations · Full text

Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding

Hugh Harley, Timothy R. Morgan, Allan G. Redeker et al. · Gastroenterology · 1986 · 109 citations

Hepatology, End-to-side Portacaval Shunt, Surgery +7